🟢 20/20 Biolabs is trading 11.48% up in after-hours trading — catalyst remains unidentified

20/20 Biolabs is trading 11.48% up at $0.41 in after-hours trading; the catalyst remains unidentified.

• No verified company-specific announcement on October 12 explains the move.
• The latest company news located was its October 2 announcement that executives would attend the Maxim Growth Summit on October 13–14; this does not establish a cause for the rise.
• The broader market was mixed, with no strong same-direction move clearly explaining the gain.